Maria G. Minissale

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Induction and Prolonged Induction With Mirikizumab in Ulcerative Colitis-A Prospective, Real-World Study From the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).

Induction and Prolonged Induction With Mirikizumab in Ulcerative Colitis-A Prospective, Real-World Study From the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).

Journal: United European gastroenterology journal

Published: January 14, 2026

Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study.

Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study.

Journal: Journal of Crohn's & colitis

Published: October 13, 2025

Point-of-Care Testing and Treatment of Hepatitis C Virus in Prisons: The SINTESI Project in Sicily.

Point-of-Care Testing and Treatment of Hepatitis C Virus in Prisons: The SINTESI Project in Sicily.

Journal: Mayo Clinic proceedings. Innovations, quality & outcomes

Published: July 29, 2025

HCV Screening in a Sicilian Centre: A Descriptive Cohort Profile.

HCV Screening in a Sicilian Centre: A Descriptive Cohort Profile.

Journal: Viruses

Published: July 07, 2025

The Effectiveness of Risankizumab as Induction Therapy for Crohn's Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases.

The Effectiveness of Risankizumab as Induction Therapy for Crohn's Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases.

Journal: Inflammatory bowel diseases

Published: July 12, 2024

N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review.

N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review.

Journal: Frontiers in pharmacology

Published: December 03, 2021

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.

Journal: Inflammatory bowel diseases

Published: November 26, 2021

Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know?

Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know?

Journal: GastroHep

Published: February 12, 2021

Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort.

Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort.

Journal: Internal and emergency medicine

Published: February 04, 2021

The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center.

The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center.

Journal: BioMed research international

Published: November 27, 2019

A questionable diagnosis in a woman with drowsiness.

A questionable diagnosis in a woman with drowsiness.

Journal: Internal and emergency medicine

Published: August 14, 2019

Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis?

Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis?

Journal: Internal and emergency medicine

Published: March 07, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026